Clinical Validation of Tele-stethoscope System Digital
Launched by SOCIEDAD ESPAÑOLA DE NEUMOLOGÍA Y CIRUGÍA TORÁCICA · Jul 12, 2018
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent sign.
- • Pacient admitted to hospital with any disease but no inestable disease.
- Exclusion Criteria:
- • The lack of informed consent.
- • Inestable disease.
About Sociedad Española De Neumología Y Cirugía Torácica
The Sociedad Española de Neumología y Cirugía Torácica (SEPAR) is a prominent Spanish organization dedicated to advancing research, education, and clinical practice in the fields of pulmonology and thoracic surgery. Committed to improving respiratory health, SEPAR fosters collaboration among healthcare professionals and researchers to promote innovative clinical trials and evidence-based practices. Through its rigorous scientific approach and emphasis on patient-centered care, SEPAR aims to enhance treatment outcomes and contribute to the overall understanding of respiratory diseases, ultimately benefiting patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cáceres, , Spain
Patients applied
Trial Officials
Jaime Corral, MD
Principal Investigator
Hospital San Pedro de Alcántara. Cáceres. Spain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials